Abiomed signs $16m+ Japanese deal:
This article was originally published in Clinica
Executive Summary
Abiomed, the Danvers, Massachusetts-based maker of temporary cardiac support systems, has signed a distribution deal for Japan that it said could be worth more than $16m. Local distribution company Medix Japan will carry out clinical trials and eventually distribute Abiomed's Impella and AB5000 circulatory support systems. It has agreed to purchase at least $11m-worth of Impella products in the first 18 months following their Japanese regulatory approvals, and has also committed to purchasing other products beginning in Abiomed's fiscal first quarter (ie, between April and June 2007).